2-169808892-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003142.5(SSB):āc.659A>Cā(p.Asp220Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,597,934 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003142.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSB | NM_003142.5 | c.659A>C | p.Asp220Ala | missense_variant | 8/12 | ENST00000260956.9 | NP_003133.1 | |
SSB | NM_001294145.2 | c.659A>C | p.Asp220Ala | missense_variant | 8/12 | NP_001281074.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSB | ENST00000260956.9 | c.659A>C | p.Asp220Ala | missense_variant | 8/12 | 1 | NM_003142.5 | ENSP00000260956.4 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000271 AC: 68AN: 251124Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135812
GnomAD4 exome AF: 0.000263 AC: 380AN: 1445570Hom.: 2 Cov.: 28 AF XY: 0.000260 AC XY: 187AN XY: 720174
GnomAD4 genome AF: 0.000197 AC: 30AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.659A>C (p.D220A) alteration is located in exon 8 (coding exon 7) of the SSB gene. This alteration results from a A to C substitution at nucleotide position 659, causing the aspartic acid (D) at amino acid position 220 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at